Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone

Key facts

Sponsor

St. Louis University

Intervention

Zoledronic Acid(drug)

Enrollment

120 target

Eligibility

18 years · All sexes

Timeline

2018 – 2028

Study locations (16)

• University of California - Los Angeles, Los Angeles, California, United States
• Indiana University, Indianapolis, Indiana, United States
• University of Iowa, Iowa City, Iowa, United States
• University of Kansas, Overland Park, Kansas, United States
• Johns Hopkins University Hospital, Baltimore, Maryland, United States
• Massachusetts General Hospital, Boston, Massachusetts, United States
• Boston Children's Hospital, Boston, Massachusetts, United States
• Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
• Saint Louis University, St Louis, Missouri, United States
• Wake Forest University, Winston-Salem, North Carolina, United States
• Cleveland Clinic, Cleveland, Ohio, United States
• University of Oklahoma, Oklahoma City, Oklahoma, United States
• Allegheny-Singer Research Institute, Pittsburgh, Pennsylvania, United States
• University of Washington, Seattle, Washington, United States
• McGill University Health Centre, Montreal, Quebec, Canada
• +1 more locations on ClinicalTrials.gov

Collaborators

Orthopedic Research and Education Foundation · Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) · University of Iowa · Johns Hopkins University · McGill University Health Centre/Research Institute of the McGill University Health Centre · The Cleveland Clinic · Wake Forest University · University of Kansas · Indiana University · University of Oklahoma · Beth Israel Deaconess Medical Center · Boston Children's Hospital · American Academy of Orthopaedic Surgeons · Massachusetts General Hospital · All India Institute of Medical Sciences · University of Washington · University of California

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Giant cell tumor of bone

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE4NCT07315828
  Accuracy of Indocyanine Green (ICG) Fluorescence Imaging in Giant Cell Tumor of Bone Surgery
  Shanghai Jiao Tong University Affiliated Sixth People's Hospital
• RECRUITINGNCT07227961
  PROMIS and Mobility Evaluation in Sarcoma Patients
  University of Calgary
• RECRUITINGPHASE1, PHASE2NCT06647901
  Efficacy of ICG-based NIR Imaging in Intralesional Curettage of Giant Cell Tumors of Bone in Limbs: a Prospective, Single-center, Single-arm, Open Study
  Tang Xiaodong
• ACTIVE NOT RECRUITINGPHASE4NCT04586660
  Study of XGEVA® (Denosumab) in Chinese Adults and Skeletally Mature Adolescents With Giant Cell Tumor of the Bone
  Amgen
• RECRUITINGPHASE2NCT05595603
  Zoledronic Acid-loaded Bone Cement as a Local Adjuvant Therapy for Giant Cell Bone Tumor After Intralesional Curettage
  Second Affiliated Hospital, School of Medicine, Zhejiang University

See all trials for Giant cell tumor of bone →